Literature DB >> 19730262

How to find, recruit and maintain rare blood donors.

Sandra Taddie Nance1.   

Abstract

PURPOSE OF REVIEW: Since the early 1960s, it was recognized that patients with very complex serology may be limited in the availability of rare blood for transfusion. Over the years, there have been publications about the quest to meet those needs. Although the world's literature on how to find, recruit and maintain rare blood donors is not overwhelming, there are quite a few pearls. This review will seek out those pearls published in 2007-2009 and provides some insight from a perspective of having a responsibility for a nation of patients requiring rare blood for over 15 years. RECENT
FINDINGS: Most pertinent publications have focused on a particular country and the data gathered by a particular regional area or the national rare donor program. It is clear that the definition of 'rare' varies from country to country. A blood type rare in one country may not be considered rare in another. A few of the publications that will be reviewed are specific to donor recruitment or specific details regarding a particular blood type. Recently, with the advent of semi-automated equipment to assist in DNA analysis, there has been a volley of articles on the use of this equipment.Without effective rare donor programs, there is a risk that transfusion needs may not be met. Hemovigilance concentrates on adverse events related to blood transfusions, and the event that happens when rare blood is not available may be that the patient dies without the transfusion they need.
SUMMARY: The need for rare blood has been recognized for nearly 50 years, and there are some very effective programs across the world, but not all the areas of the world are equally supplied. The International Society of Blood Transfusion Working Party for Rare Donors is a vital link in the worldwide goal of providing rare blood to the patients who need it.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19730262     DOI: 10.1097/MOH.0b013e3283316bed

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  9 in total

1.  A new strategy to identify rare blood donors: single polymerase chain reaction multiplex SNaPshot reaction for detection of 16 blood group alleles.

Authors:  Flavia Roche Moreira Latini; Diana Gazito; Carine Prisco Arnoni; Janaína Guilhem Muniz; Rosangela de Medeiros Person; Fabricio Oliveira Carvalho; Wilson Baleotti; Lilian Castilho; José Augusto Barreto
Journal:  Blood Transfus       Date:  2013-04-15       Impact factor: 3.443

2.  Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype.

Authors:  Francesca Masiello; Valentina Tirelli; Massimo Sanchez; Emile van den Akker; Girelli Gabriella; Maurizio Marconi; Maria Antonietta Villa; Paolo Rebulla; Ghazala Hashmi; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Transfusion       Date:  2013-09-04       Impact factor: 3.157

3.  The Lombardy Rare Donor Programme.

Authors:  Nicoletta Revelli; Maria Antonietta Villa; Cinzia Paccapelo; Maria Cristina Manera; Paolo Rebulla; Anna Rita Migliaccio; Maurizio Marconi
Journal:  Blood Transfus       Date:  2013-02-21       Impact factor: 3.443

4.  Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells.

Authors:  Kiyosumi Ochi; Naoya Takayama; Shoichi Hirose; Tatsutoshi Nakahata; Hiromitsu Nakauchi; Koji Eto
Journal:  Stem Cells Transl Med       Date:  2014-05-29       Impact factor: 6.940

5.  Towards a Regional Registry of Extended Typed Blood Donors: Molecular Typing for Blood Group, Platelet and Granulocyte Antigens.

Authors:  Jan Portegys; Gabi Rink; Pia Bloos; Erwin A Scharberg; Harald Klüter; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2018-09-24       Impact factor: 3.747

6.  Rare blood donor program in the country: Right time to start.

Authors:  Ravneet Kaur; Ashish Jain
Journal:  Asian J Transfus Sci       Date:  2012-01

7.  Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing.

Authors:  Joseph Hawksworth; Timothy J Satchwell; Marjolein Meinders; Deborah E Daniels; Fiona Regan; Nicole M Thornton; Marieangela C Wilson; Johannes Gg Dobbe; Geert J Streekstra; Kongtana Trakarnsanga; Kate J Heesom; David J Anstee; Jan Frayne; Ashley M Toye
Journal:  EMBO Mol Med       Date:  2018-06       Impact factor: 12.137

Review 8.  Interventions to Increase Blood Donation among Ethnic/Racial Minorities: A Systematic Review.

Authors:  Jennifer K Makin; Kate L Francis; Michael J Polonsky; Andre M N Renzaho
Journal:  J Environ Public Health       Date:  2019-04-15

9.  Disruption of SMIM1 causes the Vel- blood type.

Authors:  Bryan A Ballif; Virginie Helias; Thierry Peyrard; Cécile Menanteau; Carole Saison; Nicole Lucien; Sébastien Bourgouin; Maude Le Gall; Jean-Pierre Cartron; Lionel Arnaud
Journal:  EMBO Mol Med       Date:  2013-04-15       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.